Richard Day
Richard Day
Professor of Regenerative Medicine Technology, University College London
Потвърден имейл адрес: ucl.ac.uk - Начална страница
Collagen—emerging collagen based therapies hit the patient
EA Abou Neel, L Bozec, JC Knowles, O Syed, V Mudera, R Day, JK Hyun
Advanced drug delivery reviews 65 (4), 429-456, 2013
Bioactive Glass Stimulates the Secretion of Angiogenic Growth Factors and Angiogenesis in Vitro
RM Day
Tissue engineering 11 (5-6), 768-777, 2005
Assessment of polyglycolic acid mesh and bioactive glass for soft-tissue engineering scaffolds
RM Day, AR Boccaccini, S Shurey, JA Roether, A Forbes, LL Hench, ...
Biomaterials 25 (27), 5857-5866, 2004
Small intestinal enteropathy with epithelial IgG and complement deposition in children with regressive autism
F Torrente, P Ashwood, R Day, N Machado, RI Furlano, A Anthony, ...
Molecular Psychiatry 7 (4), 375-382, 2002
Colonic CD8 and γδ T-cell infiltration with epithelial damage in children with autism
RI Furlano, A Anthony, R Day, A Brown, L McGarvey, MA Thomson, ...
The Journal of pediatrics 138 (3), 366-372, 2001
Release of angiogenic growth factors from cells encapsulated in alginate beads with bioactive glass
H Keshaw, A Forbes, RM Day
Biomaterials 26 (19), 4171-4179, 2005
Evaluation of decellularization protocols for production of tubular small intestine submucosa scaffolds for use in oesophageal tissue engineering
O Syed, NJ Walters, RM Day, HW Kim, JC Knowles
Acta biomaterialia 10 (12), 5043-5054, 2014
Superparamagnetic iron oxide nanoparticle targeting of MSCs in vascular injury
J Riegler, A Liew, SO Hynes, D Ortega, T O’Brien, RM Day, T Richards, ...
Biomaterials 34 (8), 1987-1994, 2013
Preparation and characterisation of poly (lactide-co-glycolide)(PLGA) and PLGA/Bioglass® composite tubular foam scaffolds for tissue engineering applications
AR Boccaccini, JJ Blaker, V Maquet, RM Day, R Jérôme
Materials Science and Engineering: C 25 (1), 23-31, 2005
Novel fabrication techniques to produce microspheres by thermally induced phase separation for tissue engineering and drug delivery
JJ Blaker, JC Knowles, RM Day
Acta biomaterialia 4 (2), 264-272, 2008
Heparin, cell adhesion, and pathogenesis of inflammatory bow el disease
R Day, A Forbes
The Lancet 354 (9172), 62-65, 1999
Quantifying the anisotropy and tortuosity of permeable pathways in clay-rich mudstones using models based on X-ray tomography
NR Backeberg, F Iacoviello, M Rittner, TM Mitchell, AP Jones, R Day, ...
Scientific Reports 7 (1), 1-12, 2017
In vitro and in vivo analysis of macroporous biodegradable poly(D,L‐lactide‐co‐glycolide) scaffolds containing bioactive glass
RM Day, V Maquet, AR Boccaccini, R Jérôme, A Forbes
Journal of Biomedical Materials Research Part A: An Official Journal of The …, 2005
Effect of particulate bioactive glasses on human macrophages and monocytes in vitro
RM Day, AR Boccaccini
Journal of Biomedical Materials Research Part A: An Official Journal of The …, 2005
Reduced heparan sulfate accumulation in enterocytes contributes to protein-losing enteropathy in a congenital disorder of glycosylation
V Westphal, S Murch, S Kim, G Srikrishna, B Winchester, R Day, ...
The American journal of pathology 157 (6), 1917-1925, 2000
Changes in the expression of syndecan-1 in the colorectal adenoma–carcinoma sequence
RM Day, X Hao, M Ilyas, P Daszak, IC Talbot, A Forbes
Virchows Archiv 434 (2), 121-125, 1999
In vivo characterisation of a novel bioresorbable poly (lactide-co-glycolide) tubular foam scaffold for tissue engineering applications
RM Day, AR Boccaccini, V Maquet, S Shurey, A Forbes, SM Gabe, ...
Journal of Materials Science: Materials in Medicine 15 (6), 729-734, 2004
Cantharidin blisters: a technique for investigating leukocyte trafficking and cytokine production at sites of inflammation in humans
RM Day, M Harbord, A Forbes, AW Segal
Journal of immunological methods 257 (1-2), 213-220, 2001
Does cross-reactivity between mycobacterium avium paratuberculosis and human intestinal antigens characterize Crohn’s disease?
D Polymeros, DP Bogdanos, R Day, D Arioli, D Vergani, A Forbes
Gastroenterology 131 (1), 85-96, 2006
Impaired neutrophil chemotaxis in Crohn's disease relates to reduced production of chemokines and can be augmented by granulocyte‐colony stimulating factor
MWN Harbord, DJB Marks, A Forbes, SL Bloom, RM Day, AW Segal
Alimentary pharmacology & therapeutics 24 (4), 651-660, 2006
Системата не може да изпълни операцията сега. Опитайте отново по-късно.
Статии 1–20